Literature DB >> 28616966

Magnetic Resonance Imaging-Guided Multi-Drug Chemotherapy and Photothermal Synergistic Therapy with pH and NIR-Stimulation Release.

Ji-Chun Yang1, Yang Chen2, Yu-Hao Li2, Xue-Bo Yin1,3.   

Abstract

The combination of multidrug chemotherapy and photothermal therapy (PTT) enhances cancer therapeutic efficacy. Herein, we develop a simple and smart pH/NIR dual-stimulus-responsive degradable mesoporous CoFe2O4@PDA@ZIF-8 sandwich nanocomposite. The mesoporous CoFe2O4 core acts as T2-weighted magnetic resonance (MR) imaging probe, PTT agent, and loading platform of hydrophilic doxorubicin (DOX). A polydopamine (PDA) layer is used to avoid the premature leakage of DOX before arriving at tumor site, enhance PTT efficiency, and facilitate the integration of ZIF-8 (a kind of metal-organic framework). The ZIF-8 shell serves to encapsulate hydrophobic camptothecin (CPT) and as the switch for the pH and NIR stimulation-responsive release of the two drugs. Therefore, T2-weighted MR imaging-guided multidrug chemotherapy and PTT synergistic treatment is achieved. Two kinds of anticancer drugs, hydrophilic DOX and hydrophobic CPT, are successfully loaded in CoFe2O4 and ZIF-8, respectively, so no mutual interference between the two drugs exists. A unique two-stage stepwise release process is exhibited for CPT and DOX with an interval of 12 h to improve the anticancer efficacy under the acidic microenvironment of tumor tissue. NIR irradiation achieves the burst drug-release and PTT after laser stimulation, simultaneously. With this smart design, high drug concentration is achieved at the tumor site by quick release, especially for the therapeutic drugs that show nonlinear pharmacokinetics, and PTT is integrated efficiently. Furthermore, negligible biotoxicity and a remarkable synergic antitumor effect of the hybrid nanocomposites are validated by HepG2 cells and tumor-bearing mice as models. Our multidrug delivery-releasing composite improves tumor therapeutic efficiency significantly compared with a single-drug chemotherapy system. The simple multifunctional composite system can be applied as an effective platform for personal nanomedicine with diagnosis, smart drug delivery, and cancer treatment through its remarkable photothermal property and controllable multidrug release.

Entities:  

Keywords:  CoFe2O4@PDA@ZIF-8; T2-weighted magnetic resonance imaging; multidrug chemotherapy; photothermal therapy; sandwich hybrid nanocomposite

Mesh:

Substances:

Year:  2017        PMID: 28616966     DOI: 10.1021/acsami.7b06105

Source DB:  PubMed          Journal:  ACS Appl Mater Interfaces        ISSN: 1944-8244            Impact factor:   9.229


  18 in total

Review 1.  Inorganic nanomaterials for chemo/photothermal therapy: a promising horizon on effective cancer treatment.

Authors:  Mona Khafaji; Masoud Zamani; Mortaza Golizadeh; Omid Bavi
Journal:  Biophys Rev       Date:  2019-05-17

Review 2.  Recent developments on zinc(ii) metal-organic framework nanocarriers for physiological pH-responsive drug delivery.

Authors:  Weicong Liu; Ying Pan; Weiwei Xiao; Hongjia Xu; Dong Liu; Fei Ren; Xinsheng Peng; Jianqiang Liu
Journal:  Medchemcomm       Date:  2019-10-17       Impact factor: 3.597

3.  Tuning the microstructural and magnetic properties of CoFe2O4/SiO2 nanocomposites by Cu2+ doping.

Authors:  Jie Hua; Zeyuan Cheng; Zihang Chen; He Dong; Peiding Li; Jin Wang
Journal:  RSC Adv       Date:  2021-08-02       Impact factor: 3.361

4.  Metal-organic framework-coated magnetite nanoparticles for synergistic magnetic hyperthermia and chemotherapy with pH-triggered drug release.

Authors:  Jiajie Chen; Jiaxing Liu; Yaping Hu; Zhengfang Tian; Yufang Zhu
Journal:  Sci Technol Adv Mater       Date:  2019-10-24       Impact factor: 8.090

5.  Therapeutic Application of Metal-Organic Frameworks Composed of Copper, Cobalt, and Zinc: Their Anticancer Activity and Mechanism.

Authors:  Ihn Han; Seung Ah Choi; Do Nam Lee
Journal:  Pharmaceutics       Date:  2022-02-08       Impact factor: 6.321

Review 6.  Recent advances of sorafenib nanoformulations for cancer therapy: Smart nanosystem and combination therapy.

Authors:  Fangmin Chen; Yifan Fang; Xiang Chen; Rui Deng; Yongjie Zhang; Jingwei Shao
Journal:  Asian J Pharm Sci       Date:  2020-08-21       Impact factor: 6.598

7.  Cyclodextrin-Based Magnetic Nanoparticles for Cancer Therapy.

Authors:  Radosław Mrówczyński; Artur Jędrzak; Kosma Szutkowski; Bartosz F Grześkowiak; Emerson Coy; Roksana Markiewicz; Teofil Jesionowski; Stefan Jurga
Journal:  Nanomaterials (Basel)       Date:  2018-03-16       Impact factor: 5.076

8.  An "all-in-one" antitumor and anti-recurrence/metastasis nanomedicine with multi-drug co-loading and burst drug release for multi-modality therapy.

Authors:  Ji-Chun Yang; Yue Shang; Yu-Hao Li; Yu Cui; Xue-Bo Yin
Journal:  Chem Sci       Date:  2018-07-30       Impact factor: 9.825

9.  Multivariate Modulation of the Zr MOF UiO-66 for Defect-Controlled Combination Anticancer Drug Delivery.

Authors:  Isabel Abánades Lázaro; Connor J R Wells; Ross S Forgan
Journal:  Angew Chem Int Ed Engl       Date:  2020-02-04       Impact factor: 15.336

Review 10.  Advances and Potentials of Polydopamine Nanosystem in Photothermal-Based Antibacterial Infection Therapies.

Authors:  Shuhao Fan; Wensen Lin; Yifan Huang; Jiaojiao Xia; Jun-Fa Xu; Junai Zhang; Jiang Pi
Journal:  Front Pharmacol       Date:  2022-03-07       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.